Compounding pharmacyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 16, 2026, FDA's public records list Hiers Enterprises, LLC dba Northwest Compounding Pharmacy with 17 drug recalls. The most recent is a drug recall dated Jan 2, 2019: Methocarbamol liquid 100mg/ml, RX, glass vial.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Jan 2, 2019 | Methocarbamol liquid 100mg/ml, RX, glass vialClass II · Lack of sterility assurance. | Drug recalls |
| Jan 2, 2019 | Lidocaine gel 2%, RX, plastic dropperClass II · Lack of sterility assurance. | Drug recalls |
| Jan 2, 2019 | Hydroxyprogesterone liquid, 250mg/ml, RX, glass vialClass II · Lack of sterility assurance. | Drug recalls |
| Jan 2, 2019 | Glutathione liquid, 200mg/ml, RxClass II · Lack of sterility assurance. | Drug recalls |
| Jan 2, 2019 | MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vialClass II · Lack of sterility assurance. | Drug recalls |
| Jan 2, 2019 | Lidocaine gel 1%, RX, plastic dropperClass II · Lack of sterility assurance. | Drug recalls |
| Jan 2, 2019 | HCG liquid, 1000u/ml, RX, glass vial, variousClass II · Lack of sterility assurance. | Drug recalls |
| Jan 2, 2019 | Testosteron Cypionate liquid 200mg/ml, RX, glass vialClass II · Lack of sterility assurance. | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built